Finance

Beta
Lists
HNSA:STO
Hansa Biopharma AB
SEK 31.36
-0.38%
(-0.12) 1D
Jun 3, 5:29:35 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for HNSA...
Open
SEK 31.24
High
SEK 31.70
Low
SEK 30.90
Mkt. cap
3.19B
Avg. vol.
587.40K
Volume
209.12K
52-wk high
SEK 42.98
52-wk low
SEK 22.82
EPS
-SEK 7.87
Shares outstanding
101.76M
No. of employees
122
Open
SEK 31.24
High
SEK 31.70
Low
SEK 30.90
Mkt. cap
3.19B
Avg. vol.
587.40K
Volume
209.12K
52-wk high
SEK 42.98
52-wk low
SEK 22.82
EPS
-SEK 7.87
Shares outstanding
101.76M
No. of employees
122
News stories
From sources across the web
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees122
Founded2007
Headquarters-
SectorBiotechnology
Websitehansabiopharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
49.12M
30.80M
75.99M
34.57M
Cost of goods sold
18.27M
20.11M
24.66M
13.78M
Cost of revenue
18.27M
20.11M
24.66M
13.78M
Research and development expenses
95.84M
70.21M
74.43M
57.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90.52M
88.41M
101.62M
105.56M
Operating expense
186.32M
160.41M
176.02M
162.90M
Total operating expenses
204.59M
180.52M
200.67M
176.68M
Operating income
-155.47M
-149.71M
-124.68M
-142.11M
Other non operating income
-
-
-
-
EBT including unusual items
-178.04M
-147.56M
-169.50M
-195.87M
EBT excluding unusual items
-118.59M
-147.56M
-169.50M
-195.87M
Income tax expense
842.00K
693.00K
396.00K
453.00K
Effective tax rate
-0.47%
-0.47%
-0.23%
-0.23%
Other operating expenses
-34.00K
1.79M
-34.00K
-
Net income
-178.88M
-148.26M
-169.90M
-196.32M
Net profit margin
-364.16%
-481.29%
-223.58%
-567.89%
Earnings per share
-1.69
-1.75
-1.62
-1.93
Interest and investment income
49.50M
10.28M
-
2.55M
Interest expense
-13.32M
-10.23M
-208.06M
-55.92M
Net interest expenses
36.18M
49.00K
-208.06M
-53.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
-154.83M
-149.07M
-124.05M
-141.48M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer